Speaker Bios - Saturday


Friday  |  Saturday

Lucile Adams-Campbell, PhD
Associate Director, Minority Health and Health Disparities Research,
Georgetown Lombardi Comprehensive Cancer Center

Dr. Adams-Campbell is an epidemiologist who specializes in community health research, interventions and outreach among populations at the greatest risk for developing cancer. She has participated and led several large cohort studies of African-American women and played a leading role in bringing the Boston University Black Women's Health Study to the District of Columbia. Through community-based interventions involving diet and exercise, she hopes to decrease mortality from cancer and related conditions among minorities and the underserved.

Amanda Bennett
Author, “The Cost of Hope: A Memoir”; Executive Editor for Bloomberg News

Before becoming executive editor for Bloomberg News, Ms. Bennett was editor of various major newspapers, including The Philadelphia Inquirer, the Herald-Leader in Lexington, Kentucky and The Oregonian. Ms. Bennett served as a reporter for The Wall Street Journal for more than 20 years. In 1997, she shared the Pulitzer Prize for national reporting with her Journal colleagues, and in 2001, during her tenure at The Oregonian, that paper won a Pulitzer for public service. Ms. Bennett is the author of several books including: “The Cost of Hope;” “In Memoriam;” co-authored with Terence B. Foley; “The Man Who Stayed Behind,” co-authored with Sidney Rittenberg; and “Death of the Organization Man.”

Julie C. Feurtado, RN, BSN, OCN
Clinical Nurse Coordinator, Georgetown Lombardi Comprehensive Cancer Center

Ms. Feurtado works as a Clinical Nurse Coordinator at Georgetown Lombardi specializing in the care of gastrointestinal cancers. Ms. Feurtado previously served 11 years as a Navy Nurse Corps Officer after graduating from the University of Virginia. During this time, Ms. Feurtado received three Navy and Marine Core Achievement Medals and a Navy Meritorious Service Award.

Jim Luecht, CCRP
Lung Cancer and Brain Tumor Clinical Research Coordinator,
Georgetown Lombardi Comprehensive Cancer Center

Mr. Luecht recently joined the Georgetown Lombardi team after spending six years in community based medical oncology. He has had a special emphasis on lung cancer clinical trials, and is also actively involved with the Experimental Therapeutics Phase I Program, which offers our patients early phase and novel options in their cancer treatment.

Subha Madhavan, PhD
Director of the Innovation Center for Biomedical Informatics,
Georgetown University Medical Center

Dr. Madhavan leads several informatics efforts at Georgetown, including the Georgetown Database of Cancer, a tool for both researchers and clinicians to realize the goals of personalized medicine, as well as the NIH In Silico Research Center for Excellence. Prior to joining Georgetown, Dr. Madhavan served as associate director of product and program management at NCI's Center for Biomedical Informatics and Information technology. Her work has helped enable researchers and physician scientists use cutting edge biomedical informatics solutions to identify better therapies for cancer.

John L. Marshall, MD
Director, Ruesch Center for the Cure of Gastrointestinal Cancers
Georgetown Lombardi Comprehensive Cancer Center

Dr. Marshall is a global leader in the research and development of drugs for colon cancer and other gastrointestinal cancers. He is the principal investigator of over 150 clinical trials, at the local as well as national levels. Besides his role as head of the Ruesch Center, Dr. Marshall is chief of the Division of Hematology/Oncology for MedStar Georgetown University Hospital and associate director for clinical research of Georgetown Lombardi Comprehensive Cancer Center.
He is widely published in the field of clinical oncology, reviews manuscripts for eight journals and holds peer-reviewed grants from the National Institutes of Health. Dr. Marshall's own research focuses on the development of a novel vaccine for the treatment of advanced colon cancer. For over a decade, he has directed Georgetown Lombardi's Experimental Therapeutics Program while also maintaining his regular clinical practice. Seeing about 60 patients each week, Dr. Marshall specializes in cancers of the gastrointestinal tract at all stages of the disease.

Margo Michaels, MPH
Executive Director and President of Education Network to
Advance Cancer Clinical Trials (ENACCT)

Over the last 15 years, Ms. Michaels has developed innovative programs to educate cancer advocates, community leaders and health care professionals about policy and science issues related to cancer and cancer clinical trials. She is considered a national expert in community-based education efforts around cancer clinical research. Prior to starting ENACCT, she served as branch chief at NCI's Public and Survivor Education Branch; as lead consultant to the Clinical Research: Affiliates Funding Trials (CRAFT) program at the Susan G. Komen for the Cure, and as director of the National Breast Cancer Coalition's Project LEAD.